PROOF-HD is a Phase 3 clinical study that evaluates the efficacy and safety of pridopidine in patients with early stage of Huntington Disease. Pridopidine is a small molecule developed by Prilenia for the treatment of neurodegenerative disorders such as HD.
According to Prilenia, the Pridopidine is an oral drug administered in a small easy-to-swallow capsule twice a day, which enters the brain and spinal cord, where it activates a protein called the sigma-1 receptor (S1R). Activation of the S1R by pridopidine enhances the clearance of toxic proteins, enhances energy production, and reduces cellular stress and inflammation. These mechanisms are crucial for a neuron’s function and survival.
25 Years and older
(Adult, Older Adult)
All
No
TRIAL SITE: Medizinische Universität Innsbruck
Adress: Innsbruck
TRIAL SITE: Centrum extrapyramidových onemocnění
Address: Prague
TRIAL SITE: Centre Hospitalier Universitaire (CHU) Henri Mondor
Address: Paris
TRIAL SITE:Hôpitaux Universitaires de Marseille Timone
Address: Marseille
TRIAL SITE: Centre Hospitalier Universitaire (CHU) of Lille – Hôpital Roger Salengro
Address: Lille
TRIAL SITE: Euregional Huntington Center Aachen (EHZA)
Address: Aachen
TRIAL SITE: George Huntington Institut
Address: Münster
TRIAL SITE: Huntington Center North Rhine-Westphalia,
Department of Neurology,
Ruhr-University Bochum,
St. Josef-Hospital Bochum
Address: Bochum
TRIAL SITE: Kbo-Isar-Amper-Klinikum Taufkirchen (Vils)
Address: Taufkirchen (Vils)
TRIAL SITE: University of Lübeck
Address: Lübeck
TRIAL SITE: Ulm University
Address: Ulm
TRIAL SITE: IRCCS Istituto delle Scienze Neurologiche di Bologna
Address: Bologna
TRIAL SITE: Fondazione IRCCS Istituto Neurologico Carlo Besta
Address: Milano
TRIAL SITE: CSS-Mendel Institute at IRCCS Casa Sollievo della Sofferenza Research Hospital
Address: Roma
TRIAL SITE:Universita’ di Bari
Address: Bari
TRIAL SITE:Università di Napoli Federico II
Address: Naples
TRIAL SITE: Maastricht University
Address: Maastricht
TRIAL SITE:Leiden University Medical Center
Address: Leiden
TRIAL SITE: Szpital Specjalistyczny Swietego Wojciecha
Address: Gdansk
TRIAL SITE: Krakowska Akademia Neurologii
Address: Krakow
TRIAL SITE:Instytut Psychiatrii i Neurologii
Address: Warsaw
TRIAL SITE:Hospital de la Santa Creu i Sant Pau
Address: Barcelona
TRIAL SITE: Burgos Foundation for Health Research
Address: Burgos
TRIAL SITE: Fundacion Hospital Universitario La Fé
Address: Valencia
TRIAL SITE:Hospital Ramón y Cajal
Address: Madrid
TRIAL SITE: Cardiff University
Address: Cardiff , Wales
TRIAL SITE: Aberdeen University
Address: Aberdeen, Scotland
TRIAL SITE: Newcastle upon Tyne Hospitals NHS Foundation
Address:Newcastle, England
a single-letter spelling difference in a gene. SNPs, pronounced ‘snips’, are common and most don’t change the function of the gene.
You do not know if you carry the genetic mutation for HD gene
A standardized rating scale for function in HD, used to assess capacity to work, handle finances, perform domestic chores and self-care tasks.
Scores range from 0 to 13, with higher scores indicating better functional capacity.
means that neither the participant nor the clinical trial doctor can choose or know the group the participant is in until the trial is over. This approach helps to prevent bias.
A trial in which the patient and doctor know what drug is being used. Open label trials are susceptible to bias through placebo effects.
a technique that aims to treat or prevent diseases by modifying a person’s genes. It involves introducing, removing, or changing genetic material (DNA or RNA) within a patient’s cells.
A standardized neurological examination that aims to provide a uniform assessment of the clinical features of HD
The stretch of DNA at the beginning of the HD gene, which contains the sequence CAG repeated many times, and is abnormally long in people who will develop HD
the opposite of ‘mutant’. Wild-type huntingtin, for example, is the ‘normal’, ‘healthy’ protein
How well a person can handle a treatment without having serious or uncomfortable side effects.
Part of the brain that coordinates multiple aspects of cognition, including both motor and action planning, decision-making, motivation, reinforcement, and reward system.
A type of allocation strategy in which participants are assigned to the arms of a clinical trial by chance.
a radioactive substance that binds to a specific target in the body, allowing visualization of that target’s distribution and activity
Protein builds, maintains, and replaces the tissues in your body. The building blocks of life.
Prior to onset or diagnosis of movement symptoms.
A placebo is a dummy medicine containing no active ingredients. The placebo effect is a psychological effect that causes people to feel better even if they’re taking a pill that doesn’t work.
The movement of drugs through the body
The body’s biological response to drugs
Positron emission tomography which produces detailed 3-dimensional images of the inside of the body.
Brain cells that store and transmit information
Magentic resonance imaging: A technique using powerful magnetic fields to produce detailed images and visualizes the structure of organs, tissues, and bones
Mutant huntingtin protein. The protein produced by the faulty HD gene.
after HD diagnosis, or when symptoms are already showing
A study where each participant is looked at several times over a time period – unlike a cross-sectional study, where each participant is looked at only once
one abbreviation for the gene that causes Huntington’s disease. The same gene is also called HD and IT-15
functional MRI:As with MRI, a technique using powerful magnetic fields but focusing on brain function by measuring and mapping changes in blood flow, revealing which areas of the brain are active during specific tasks or cognitive processes
A clear fluid produced by the brain, which surrounds and supports the brain and spinal cord.
A measure of whether a treatment works or not
A type of gene silencing treatment in which specially designed DNA molecules are used to switch off a gene
a test of any kind – including blood tests, thinking tests and brain scans – that can measure or predict the progression of a disease like HD. Biomarkers may make clinical trials of new drugs quicker and more reliable
Brain-derived neurotrophic factor: a growth factor that may be able to protect neurons in HD.
one of the two copies of a gene
Liquid component of the blood.
The basic unit of heredity passed from parent to child. Genes are made up of sequences of DNA and are arranged, one after another, at specific locations on chromosomes in the nucleus of cells.
Each phase has a specific goal and involves a different number of participants. Generally, there are 4 phases (I-IV), with Phase I focusing on safety and dosage, Phase II on efficacy and side effects, Phase III on comparing the new treatment with standard treatments, and Phase IV on long-term safety monitoring.
